This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Jacobs, J. B. Articles by Friedell, G. H. Search for Related Content PubMed Articles by Jacobs, J. B. Articles by Friedell, G. H.

A Long-Term Study of Reversible and Progressive Urinary Bladder Cancer Lesions in Rats Fed N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide¹

Department of Pathology, St. Vincent Hospital, and Department of Pathology, the University of Massachusetts Medical School, Worcester, Massachusetts 01604

Hyperplasia and, ultimately, neoplasia of bladder epithelium were produced by feeding 0.2% N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) to weanling male Fischer rats. Hyperplasia induced by FANFT feeding for 2, 4, or 6 weeks, followed by feeding control diet until the end of the 84-week experiment, was reversible, and at the end of the experiment bladder epithelium in these animals was normal by light and scanning electron microscopy. Hyperplasia produced by 8 or more weeks of FANFT feeding was irreversible and by 84 weeks had resulted in bladder tumors in all animals fed FANFT for 12 or more weeks and in 4 of 5 and 6 of 7 animals fed FANFT for 8 and 10 weeks, respectively. The epithelial changes after 6 and 8 weeks of FANFT were similar by light microscopy but different by scanning electron microscopy. Pleomorphic microvilli seen with scanning electron microscopy are the hallmark of irreversible, and possibly progressive, epithelial proliferative change.

¹ Presented at the National Bladder Cancer Conference, November 28 to December 1, 1976, Miami Beach, Fla. This investigation was supported in part by USPHS Grant CA 15945 from the National Cancer Institute through the National Bladder Cancer Project.

² Presenter. To whom requests for reprints should be addressed, at the Department of Pathology, Saint Vincent Hospital.